Peralta, Pablita M.
HRN: 03-07-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
CEFTRIAXONE 1G (VIAL)
06/06/2025
06/14/2025
IV
2gms
OD
Pneumonia
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines